Unknown

Dataset Information

0

Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium.


ABSTRACT: BACKGROUND:Classification of breast cancer into intrinsic subtypes has clinical and epidemiologic importance. To examine accuracy of IHC-based methods for identifying intrinsic subtypes, a three-biomarker IHC panel was compared with the clinical record and RNA-based intrinsic (PAM50) subtypes. METHODS:Automated scoring of estrogen receptor (ER), progesterone receptor (PR), and HER2 was performed on IHC-stained tissue microarrays comprising 1,920 cases from the African American Breast Cancer Epidemiology and Risk (AMBER) consortium. Multiple cores (1-6/case) were collapsed to classify cases, and automated scoring was compared with the clinical record and to RNA-based subtyping. RESULTS:Automated analysis of the three-biomarker IHC panel produced high agreement with the clinical record (93% for ER and HER2, and 88% for PR). Cases with low tumor cellularity and smaller core size had reduced agreement with the clinical record. IHC-based definitions had high agreement with the clinical record regardless of hormone receptor positivity threshold (1% vs. 10%), but a 10% threshold produced highest agreement with RNA-based intrinsic subtypes. Using a 10% threshold, IHC-based definitions identified the basal-like intrinsic subtype with high sensitivity (86%), although sensitivity was lower for luminal A, luminal B, and HER2-enriched subtypes (76%, 40%, and 37%, respectively). CONCLUSION:Three-biomarker IHC-based subtyping has reasonable accuracy for distinguishing basal-like from nonbasal-like, although additional biomarkers are required for accurate classification of luminal A, luminal B, and HER2-enriched cancers. IMPACT:Epidemiologic studies relying on three-biomarker IHC status for subtype classification should use caution when distinguishing luminal A from luminal B and when interpreting findings for HER2-enriched cancers.

SUBMITTER: Allott EH 

PROVIDER: S-EPMC4779705 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium.

Allott Emma H EH   Cohen Stephanie M SM   Geradts Joseph J   Sun Xuezheng X   Khoury Thaer T   Bshara Wiam W   Zirpoli Gary R GR   Miller C Ryan CR   Hwang Helena H   Thorne Leigh B LB   O'Connor Siobhan S   Tse Chiu-Kit CK   Bell Mary B MB   Hu Zhiyuan Z   Li Yan Y   Kirk Erin L EL   Bethea Traci N TN   Perou Charles M CM   Palmer Julie R JR   Ambrosone Christine B CB   Olshan Andrew F AF   Troester Melissa A MA  

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20151228 3


<h4>Background</h4>Classification of breast cancer into intrinsic subtypes has clinical and epidemiologic importance. To examine accuracy of IHC-based methods for identifying intrinsic subtypes, a three-biomarker IHC panel was compared with the clinical record and RNA-based intrinsic (PAM50) subtypes.<h4>Methods</h4>Automated scoring of estrogen receptor (ER), progesterone receptor (PR), and HER2 was performed on IHC-stained tissue microarrays comprising 1,920 cases from the African American Bre  ...[more]

Similar Datasets

| S-EPMC3706735 | biostudies-literature
| S-EPMC2970720 | biostudies-literature
| S-EPMC7791620 | biostudies-literature
| S-EPMC4903103 | biostudies-literature
| S-EPMC7442834 | biostudies-literature
| S-EPMC5801839 | biostudies-literature
| S-EPMC5568081 | biostudies-literature
| S-EPMC4271113 | biostudies-literature
| S-EPMC7881184 | biostudies-literature
| S-EPMC8385191 | biostudies-literature